TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis

Journal of Clinical Gastroenterology

Volumn 47, Issue 9, 2013, Pages 773-780

  Meena, Naresh K ^a   Verma, Ravi ^a   Verma, Nirmal ^a   Ahuja, Vineet ^b   Paul, Jaishree ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Inflammatory cytokines; SNPs; Toll like receptor 4; Ulcerative colitis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 17; INTERLEUKIN 23; MESSENGER RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; COLON BIOPSY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; FEMALE; GENOTYPE; HUMANS; INDIA; INFLAMMATION MEDIATORS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 84884670733     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31828a6e93     Document Type: Article

References (43)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-429.
2. Kaser A, Sebastian Z, Richard SB. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621.
3. Verma R, Verma AK, Ahuja V, et al. Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India. J Clin Microbiol. 2010;48:4279-4282.
4. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265:2037-2048.
5. Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol. 2006;41:10-16.
6. Beutler B, Hoebe K, Du X, et al. How we detect microbes and respond to them: The Toll-like receptors and their transducers. Journal of Leukocyte Biology. 2003;74:479-485.
7. Freudenberg MA, Merlin T, Gumenscheimer M, et al. Role of lipopolysaccharide susceptibility in the innate immune response to Salmonella typhimurium infection: LPS, a primary target for recognition of Gram-negative bacteria. Microbes Infect. 2001;1213-1220.
8. Chow JC, Young DW, Golenbock DT. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem. 1999;274:10689-10692.
9. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000;68: 7010-7017.
10. Frolova L, Drastich P, Rossmann P, et al. Expression of tolllike receptor 2(TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: Upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J Histochem Cytochem. 2008;56:267-274.
11. Yu Z, Huang F, Xu N, et al. Expression of toll-like receptor 4, CD14, and NFkB in chinese patients with ulcerative colitis. J Immunoassay Immunochem. 2011;32:47-56.
12. Xiuyun S, Shi R, Zhang H, et al. The toll-like receptor 4 D299G and T399I polymorphisms are associated with Crohn's disease and ulcerative colitis: A meta-analysis. Digestion. 2010;81:69-77.
13. Torok HP, Glas J, Tonenchi L. Polymorphisms of the lipopolysaccharide signaling complex in inflammatory bowel disease: Association of a mutation in the toll-like receptor 4 gene with ulcerative colitis. Clin Immunol. 2004;112:85-91.
14. Gazouli M, Gerassimos M, Kotsinas A, et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterology. 2005;11:681-685.
15. Mekki LJ, Kharrat M, Karoui S, et al. Tolllike receptor 4 (TLR4) polymorphisms in Tunisian patients with Crohn's disease: Genotype-phenotype correlation. BMC Gastroenterology. 2009;9:62.
16. Guo QS, Xia B, Jiang Y, et al. Polymorphisms of CD14 gene and TLR4 gene are not associated with ulcerative colitis in Chinese patients. Postgrad Med J. 2005;81:526-529.
17. Shen XY, Shi RH, Wang Y. Toll-like receptor gene polymorphisms and susceptibility to inflammatory bowel disease in Chinese Han and Caucasian populations. Zhonghua Yi Xue Za Zhi. 2010;90:1416-1420.
18. Kim EJ, Chung WC, Lee KM, et al. Association between tolllike receptors/cd14 gene polymorphisms and inflammatory bowel disease in Korean population. J Korean Med Sci. 2012;27:72-77.
19. Okayama N, Fujimura K, Suehiro Y, et al. Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness. J Clin Lab Anal. 2002;16:56-58.
20. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805-820.
21. Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol. 1995;102:448-455.
22. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783-801.
23. Murch SH, Braegger CP, Walker-Smith JA, et al. Location of tumour necrosis factor a by immunohistochemistry in chronic inflammatory bowel disease. Gut. 1993;34:1705-1709.
24. Neurath MF. IL-23: A master regulator in Crohn disease. Nature Medicine. 2007;13:26-28.
25. Niessner M, Volk BA. Altered Thl/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol. 1995;101: 428-435.
26. Akazawa A, Sakaida I, Higaki S, et al. Increased expression of tumor necrosis factor-a messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase. J Gastroenterol. 2002; 37:345-353.
27. Carty E, Brabander MD, Feakins RM, et al. Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper. Gut. 2000;46:487-492.
28. Maloy KJ, Kullberg MC. IL-23 and Th17 cytokines in intestinal homeostasis. Mucosal Immunol. 2008;1:339-349.
29. Liu Z, Yadav PK, Xu X, et al. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. J Leukoc Biol. 2011;89:597-606.
30. Fujino S, Andoh A, Bamba S. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003; 52:65-70.
31. Autschbach F, Braunstein J, Helmke B, et al. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am J Pathol. 1998;153:121-130.
32. Bamba S, Andoh A, Yasui H. Regulation of IL-11 expression in intestinal myofibroblasts: Role of c-Jun AP-1- and MAPKdependent pathways. Am J Physiol Gastrointest Liver Physiol. 2003;285:G529-G538.
33. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: Controversies, consensus and implications. Gut. 2006;55:749-753.
34. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
35. Livak JK, Schmittgen TD. Analysis of relative expression data using real time quantitation PCR AND 2-DDCT method. Methods. 2001;25:402-408.
36. Franchimont D, Vermeire S, Housni H. Deficient host-bacteria interactions in inflammatory bowel disease the toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut. 2004;53:987-992.
37. Hong J, Leung E, Fraser AG. TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. J Gastroenterol Hepatol. 2007;22:1760-1766.
38. Rigoli L, Romano C, Alberto R, et al. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. World J Gastroenterol. 2008;14:4454 -4461.
39. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genetics. 2000;251:87-91.
40. Minoretti P, Gazzaruso C, Vito CD, et al. Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neuroscience Letters. 2006;391:147-149.
41. Yang XQ, Murani SE, Wimmers PK. Association of TLR4 polymorphism with cytokine expression level and pulmonary lesion score in pigs. Mol Biol Rep. 2012;39:7003-7009.
42. Yang ZH, Dai Q, Gu YJ, et al. Cytokine and chemokine modification by Toll-like receptor polymorphisms is associated with nasopharyngeal carcinoma. Cancer Sci. 2012;103: 653-658.
43. Minmin S, Xiaoqian X, Hao C, et al. Single nucleotide polymorphisms of toll-like receptor 4 decrease the risk of development of hepatocellular carcinoma. PLoS ONE. 2011;6:1-7.